Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.
Investors 1
| Date | Name | Website |
| - | Epidarex C... | epidarex.c... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 07.11.2023 | Lario Therapeutics receives “Company Making a Difference Awa... | CDLK5 Forum Award for Excellence - Company Making a Difference 2023 Pre-clinical” presented by the L... | cambridgen... |